Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02794 (
ferritin
)
17,525
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Isolated pig heart
pyruvate dehydrogenase complex
(
PDC
) has been reported to have a molecular mass of 8000 kDa (large
PDC
) and a diameter of about 45 nm. Studies were carried out to determine the size of
PDC
in situ. Active enzyme centrifugation showed that extracts of pig heart mitochondria contain, in addition to large (S20,w = 100-200 S) active complexes, catalytically active small
PDC
(S20,w = 30 S). In addition, small
PDC
(1000-3000 kDa) could be obtained by gel filtration of mitochondrial extract. If pure large
PDC
was chromatographed in Triton X-100, then a fraction of it appears in the 1000-3000-kDa range. Isolation of small
PDC
and rechromatography showed the formation of large
PDC
. Anti-
PDC
and
ferritin
-labeled second antibody were used in an attempt to determine the size of
PDC
in isolated inner membrane vesicles containing
PDC
and in permeabilized mitochondria. In both studies no large aggregates of
ferritin
particles were found which would correspond to the size of large
PDC
. The conclusion of these experiments is that
PDC
exists in situ in a smaller form than the isolated pure enzyme.
...
PMID:Electron microscopic study on the size of pyruvate dehydrogenase complex in situ. 331 61
Protein nanocompartments (PNCs) are self-assembling biological nanocages that can be harnessed as platforms for a wide range of nanobiotechnology applications. The most widely studied examples of PNCs include virus-like particles, bacterial microcompartments, encapsulin nanocompartments, enzyme-derived nanocages (such as lumazine synthase and the E2 component of the
pyruvate dehydrogenase complex
), ferritins and
ferritin
homologues, small heat shock proteins, and vault ribonucleoproteins. Structural PNC shell proteins are stable, biocompatible, and tolerant of both interior and exterior chemical or genetic functionalization for use as vaccines, therapeutic delivery vehicles, medical imaging aids, bioreactors, biological control agents, emulsion stabilizers, or scaffolds for biomimetic materials synthesis. This review provides an overview of the recent biomedical and bioengineering advances achieved with PNCs with a particular focus on recombinant PNC derivatives.
...
PMID:The biomedical and bioengineering potential of protein nanocompartments. 3229 94